BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 285 filers reported holding BIONTECH SE in Q4 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $344 | -96.7% | 4,286 | -96.2% | 0.00% | -97.2% |
| Q1 2024 | $10,275 | +32.3% | 111,398 | +51.3% | 0.04% | +20.0% |
| Q4 2023 | $7,767 | -38.4% | 73,606 | -36.6% | 0.03% | -43.4% |
| Q3 2023 | $12,608 | -17.2% | 116,071 | -17.8% | 0.05% | -15.9% |
| Q2 2023 | $15,234 | +10.1% | 141,166 | +27.0% | 0.06% | +3.3% |
| Q1 2023 | $13,842 | -70.5% | 111,127 | -64.4% | 0.06% | -73.6% |
| Q4 2022 | $46,914 | -99.6% | 312,164 | +228.3% | 0.23% | +230.0% |
| Q3 2022 | $12,838,000 | +30.4% | 95,072 | +44.0% | 0.07% | +40.0% |
| Q2 2022 | $9,843,000 | +35053.6% | 66,018 | +39910.9% | 0.05% | – |
| Q1 2022 | $28,000 | -97.6% | 165 | -96.5% | 0.00% | -100.0% |
| Q4 2021 | $1,150,000 | -98.4% | 4,666 | -98.2% | 0.00% | -98.5% |
| Q3 2021 | $71,025,000 | -52.6% | 259,375 | -61.2% | 0.27% | -51.9% |
| Q2 2021 | $149,690,000 | – | 667,832 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
| Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
| Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
| Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
| ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
| FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
| Systrade AG | 10,000 | $803,600 | 1.38% |
| HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
| CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |